This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2010-02-25 Call Agenda"

From HL7Wiki
Jump to navigation Jump to search
Line 13: Line 13:
 
# Agenda review and approval
 
# Agenda review and approval
 
# Approval of minutes from previous calls: [[2010-02-11 Call Minutes|February 11th]], [[2010-01-28 Call Minutes|Janusry 28th]] and [[2010-01-14 Call Minutes|January 14th]]
 
# Approval of minutes from previous calls: [[2010-02-11 Call Minutes|February 11th]], [[2010-01-28 Call Minutes|Janusry 28th]] and [[2010-01-14 Call Minutes|January 14th]]
 +
# Review Actions from previous meeting(s)
 +
#:'''February 11th Call'''
 +
## ACTION: Helen will discuss the DrohanHughes2009BreastModularEHR.pdf with the caEHR project team at the NCI and provide comment back to the team on how this relates to the NCI architectural plans.
 +
## ACTION: Dr. Hughes will draft some language about interoperability with the HL7 Genomics standards that can be incorporated into the Patient History section of the functional profile.
 +
## ACTION: Marla will write some specifics around pediatric oncology, items that are unique to pediatrics or how the scope of practice is defined. Take into consideration any adjustment any change we need to make to the profile.
 +
## ACTION: Christine to develop scope/introductory language on Geriatric Oncology with Dr. John.
 +
## ACTION: All team members to review glossary and submit changes/comments for next call.
 +
## ACTION: Christine will add “Nurse Navigator” to the glossary as it compares to “Care Coordinator”.
 +
## ACTION Marla to provide Helen to generic drug names so we don’t use brand names in the use case.
 
# Document Review Session  
 
# Document Review Session  
 +
## Storyboard
 +
## Glossary
 +
## Direct Care Section (DC.1 to DC.1.5)
 
# Decision on document review for next 2 weeks.  
 
# Decision on document review for next 2 weeks.  
 
# Other business
 
# Other business
Line 20: Line 32:
 
#** Guest: Dr. Juli Klemm, Associate Director, Integrative Cancer Research Products and Programs, NCI Center for Bioinformatics
 
#** Guest: Dr. Juli Klemm, Associate Director, Integrative Cancer Research Products and Programs, NCI Center for Bioinformatics
 
#** Guest: John Speakman, Associate Director, Clinical Products and Programs, NCI Center for Biomedical Informatics and Information Technology
 
#** Guest: John Speakman, Associate Director, Clinical Products and Programs, NCI Center for Biomedical Informatics and Information Technology
−
# Meeting adjourned.
+
# Meeting adjourn

Revision as of 18:36, 12 February 2010

To return to the >> Oncology EHR Functional Profile or Agendas and Minutes

HL7 Ambulatory Oncology Functional Profile Meeting

Meeting Logistics

Date/Time: Thursday, February 25, 2010 / 1:00 PM – 3:00 PM EST
Location: Telecon 866 564 2805 x9306830#
Attendees


Agenda

  1. Welcome and Introductions
  2. Agenda review and approval
  3. Approval of minutes from previous calls: February 11th, Janusry 28th and January 14th
  4. Review Actions from previous meeting(s)
    February 11th Call
    1. ACTION: Helen will discuss the DrohanHughes2009BreastModularEHR.pdf with the caEHR project team at the NCI and provide comment back to the team on how this relates to the NCI architectural plans.
    2. ACTION: Dr. Hughes will draft some language about interoperability with the HL7 Genomics standards that can be incorporated into the Patient History section of the functional profile.
    3. ACTION: Marla will write some specifics around pediatric oncology, items that are unique to pediatrics or how the scope of practice is defined. Take into consideration any adjustment any change we need to make to the profile.
    4. ACTION: Christine to develop scope/introductory language on Geriatric Oncology with Dr. John.
    5. ACTION: All team members to review glossary and submit changes/comments for next call.
    6. ACTION: Christine will add “Nurse Navigator” to the glossary as it compares to “Care Coordinator”.
    7. ACTION Marla to provide Helen to generic drug names so we don’t use brand names in the use case.
  5. Document Review Session
    1. Storyboard
    2. Glossary
    3. Direct Care Section (DC.1 to DC.1.5)
  6. Decision on document review for next 2 weeks.
  7. Other business
  8. Agenda for next meeting:
    • NCI caBIG project use of standards discussion
      • Guest: Dr. Juli Klemm, Associate Director, Integrative Cancer Research Products and Programs, NCI Center for Bioinformatics
      • Guest: John Speakman, Associate Director, Clinical Products and Programs, NCI Center for Biomedical Informatics and Information Technology
  9. Meeting adjourn
Retrieved from "https://wiki.hl7.org/w/index.php?title=2010-02-25_Call_Agenda&oldid=32769"